by admin | Apr 4, 2022 | Insights
Emerging research makes a strong case for a future where psychedelics are a regular part of psychopharmacology. Forbes takes us through four reasons why psychedelics show immense promise in the future of mental...
by admin | Apr 4, 2022 | Insights
An update on the status of psilocybin research in North Carolina: “Basically, a single dose of these drugs has this sort of robust long lasting effect with people who have difficult-to-treat depression,” said Dr. Bryan Roth, a professor at University of North...
by admin | Apr 3, 2022 | Insights
This article from 2021 provides a comprehensive primer on the steps of a clinical trial process for #psychedelic medicines in the United States. #psychedelicscience #psilocybin #psychedelicresearch #psychedelicmedicine #research Link to post Link to...
by admin | Apr 3, 2022 | Insights
“The words people used to describe their trip experiences could lead to better drugs to treat mental illness.” A team at McGill University in Montreal is using natural language processing—the technique that allows voice assistants or search engines to work...
by admin | Apr 3, 2022 | Insights
“Finding a data-driven way to structure those experiences to maximize therapeutic benefit, I think is something we can all get excited about,” says Sam Freesun Friedman, a senior machine learning scientist at Massachusetts Institute of Technology and Harvard...
by admin | Mar 24, 2022 | Insights
“Based on the growing evidence that these treatments have dramatic and unique benefits, you don’t need to take mushrooms to envision that this field has a vivid future.” The University of Calgary has joined a growing number of universities in exploring...
Recent Comments